Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoMed, Inc. Spins Out of Zyvex Labs

Abstract:
Zyvex Labs today announced its first company spinout: NanoMed, Inc. The new company was started by Rob Burgess, PhD, former Vice President of Research & Development at Zyvex Instruments, and Gareth Hughes, PhD, former Group Leader of Life Sciences at Zyvex Corporation.

NanoMed, Inc. Spins Out of Zyvex Labs

RICHARDSON, TX | Posted on August 22nd, 2007

NanoMed is focused on the application of nanotechnology in Life Sciences. The company seeks to apply nanoparticle technologies for the development of research grade reagents and cutting-edge therapeutics. In addition, NanoMed possesses a strong collection of nanotechnology platforms that are currently available for licensing. The new company leverages Zyvex's existing Life Science patents, proprietary methods, and core technologies.

"We are delighted to obtain assignment of the nanoparticle dispersion intellectual property from Zyvex Labs," said Rob Burgess, Ph.D., NanoMed's Co-Founder and Chairman of the Board. "The application of Zyvex Performance Materials' Kentera(TM) and other polymers for functionalizing carbon nanotubes will play an integral role in solidifying NanoMed's portfolio of cutting-edge nanotechnologies as they relate to the biomedical sciences. We look forward to continuing a productive partnership with Zyvex Labs and Zyvex Performance Materials."

"Rob is a focused leader with outstanding technology development skills," said Zyvex Founder Jim Von Ehr. "He also has a proven track record in growing businesses. I expect to see exciting new products from this new venture."

NanoMed's focus centers around the functionalization and specific delivery of nanoparticles for applications in various biomedical markets, including the research, diagnostics, therapeutics, and veterinary sectors. In collaboration with their strategic partners, NanoMed researchers have developed promising technologies that will allow for the effective use of nanotechnology-based solutions to address a variety of issues across multiple scientific disciplines, including basic biomedical research and applied science related to disorders such as cancer and infectious diseases.

Other founders include Rocky Draper, PhD, Professor at the University of Texas at Dallas, and Ellen Vitetta, PhD, Professor and Director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.

More information about NanoMed's technologies and business strategy can be found at http://www.nanomedinc.com/ .

####

For more information, please click here

Contacts:
NanoMed Incorporated
P.O. Box 850922
Richardson, Texas 75085-0922
United States
ph: 951-970-8525
fax: 214-440-2311

Copyright © PR Newswire Association LLC.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Acquisitions/Mergers/Splits

GLOBALFOUNDRIES Completes Acquisition of IBM Microelectronics Business: Transaction adds differentiating technologies, world-class technologists, and intellectual property July 1st, 2015

Entest BioMedical, Inc. in Discussions to Acquire Nanotechnology Delivery System for Cancer Therapy June 3rd, 2015

Evident Thermoelectrics Acquires GMZ Energy: Investment Accelerates Launch Of Evident's Thermoelectric Modules For Waste Heat May 20th, 2015

Keysight Technologies Begins Trading as Independent Company November 3rd, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project